Administration of IL-2 in March5+/f:Vav1-Cre mice showed increased efficacy in suppression of tumor growth and improvement of the overall survival comparing to that in March5+/f mice (Fig. 6f, g; Supplementary information, Fig. S7d). The gene discussed is VAV1; the disease is neoplasm.